TMEM33 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.820580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.072300E-02
Normal-vs-Stage2
1.643210E-01
Normal-vs-Stage3
9.345400E-01
Normal-vs-Stage4
1.188170E-01
Stage1-vs-Stage2
4.661600E-01
Stage1-vs-Stage3
1.138620E-01
Stage1-vs-Stage4
8.303800E-01
Stage2-vs-Stage3
1.391190E-01
Stage2-vs-Stage4
3.907600E-01
Stage3-vs-Stage4
1.724620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.914380E-01
Normal-vs-AfricanAmerican
2.023400E-01
Normal-vs-Asian
2.478800E-01
Caucasian-vs-AfricanAmerican
7.862600E-01
Caucasian-vs-Asian
5.025200E-01
AfricanAmerican-vs-Asian
4.755600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.909160E-01
Normal-vs-Female
1.724220E-01
Male-vs-Female
5.737200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.368800E-01
Normal-vs-Age(41-60Yrs)
6.664400E-02
Normal-vs-Age(61-80Yrs)
2.671800E-01
Normal-vs-Age(81-100Yrs)
1.915420E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.572000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.348000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.238400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.315620E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.447000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.016200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.589000E-01
Normal-vs-Daily Drinker
2.292600E-01
Normal-vs-Weekly Drinker
3.683400E-01
Normal-vs-Occasional Drinker
2.691900E-02
Normal-vs-Social Drinker
1.043510E-02
Non Drinker-vs-Daily Drinker
9.929600E-01
Non Drinker-vs-Weekly Drinker
6.606200E-01
Non Drinker-vs-Occasional Drinker
1.392000E-01
Non Drinker-vs-Social Drinker
4.205400E-01
Daily Drinker-vs-Weekly Drinker
6.566600E-01
Daily Drinker-vs-Occasional Drinker
1.400960E-01
Daily Drinker-vs-Social Drinker
4.382000E-01
Weekly Drinker-vs-Occasional Drinker
7.874500E-02
Weekly Drinker-vs-Social Drinker
3.095200E-01
Occasional Drinker-vs-Social Drinker
6.866800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.370600E-01
Normal-vs-Grade 2
6.064400E-01
Normal-vs-Grade 3
8.542400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.692800E-01
Grade 1-vs-Grade 3
9.381000E-01
Grade 1-vs-Grade 4
3.370600E-01
Grade 2-vs-Grade 3
1.765810E-01
Grade 2-vs-Grade 4
6.064400E-01
Grade 3-vs-Grade 4
8.542400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.448400E-01
Normal-vs-NonDiabetic
1.672410E-01
Diabetic-vs-NonDiabetic
7.054400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.430620E-01
Normal-vs-NoPancreatitis
2.081400E-01
Pancreatitis-vs-NoPancreatitis
6.866200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.025900E-04
Normal-vs-N1
1.806570E-01
N0-vs-N1
4.676000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.83019999999901E-05
Normal-vs-TP53-NonMutant
1.915120E-03
TP53-Mutant-vs-TP53-NonMutant
2.012300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
